Louisa Degenhardt1, Sarah Larney2, Gary Chan3, Timothy Dobbins2, Megan Weier3, Amanda Roxburgh2, Wayne D Hall3, Rebecca McKetin4. 1. National Drug and Alcohol Research Centre, UNSW Australia, Sydney, NSW l.degenhardt@unsw.edu.au. 2. National Drug and Alcohol Research Centre, UNSW Australia, Sydney, NSW. 3. Centre for Youth Substance Abuse Research, University of Queensland, Brisbane, QLD. 4. National Drug Research Institute, Curtin University, Perth, WA.
Abstract
OBJECTIVE: To estimate the number of regular and dependent methamphetamine users in Australia. DESIGN: Indirect prevalence estimates were made for each year from 2002-03 to 2013-14. We applied multiplier methods to data on treatment episodes for amphetamines (eg, counselling, rehabilitation, detoxification) and amphetamine-related hospitalisations to estimate the numbers of regular (at least monthly) and dependent methamphetamine users for each year. Dependent users comprised a subgroup of those who used the drug regularly, so that estimates of the sizes of these two populations were not additive. RESULTS: We estimated that during 2013-14 there were 268 000 regular methamphetamine users (95% CI, 187 000-385 000) and 160 000 dependent users (95% CI, 110 000-232 000) aged 15-54 years in Australia. This equated to population rates of 2.09% (95% CI, 1.45-3.00%) for regular and 1.24% (95% CI, 0.85-1.81%) for dependent use. The rate of dependent use had increased since 2009-10 (when the rate was estimated to be 0.74%), and was higher than the previous peak (1.22% in 2006-07). The highest rates were consistently among those aged 25-34 years, in whom the rate of dependent use during 2012-2013 was estimated to be 1.50% (95% CI, 1.05-2.22%). There had also been an increase in the rate of dependent use among those aged 15-24 years (in 2012-13 reaching 1.14%; 95% CI, 0.80-1.69%). CONCLUSIONS: There have been increases over the past 12 years in the numbers of regular and dependent methamphetamine users in Australia. Our estimates suggest that the most recent numbers are the highest for this period, and that the increase has been most marked among young adults (those aged 15-34 years). IMPLICATIONS: There is an increasing need for health services to engage with people who have developed problems related to their methamphetamine use.
OBJECTIVE: To estimate the number of regular and dependent methamphetamine users in Australia. DESIGN: Indirect prevalence estimates were made for each year from 2002-03 to 2013-14. We applied multiplier methods to data on treatment episodes for amphetamines (eg, counselling, rehabilitation, detoxification) and amphetamine-related hospitalisations to estimate the numbers of regular (at least monthly) and dependent methamphetamine users for each year. Dependent users comprised a subgroup of those who used the drug regularly, so that estimates of the sizes of these two populations were not additive. RESULTS: We estimated that during 2013-14 there were 268 000 regular methamphetamine users (95% CI, 187 000-385 000) and 160 000 dependent users (95% CI, 110 000-232 000) aged 15-54 years in Australia. This equated to population rates of 2.09% (95% CI, 1.45-3.00%) for regular and 1.24% (95% CI, 0.85-1.81%) for dependent use. The rate of dependent use had increased since 2009-10 (when the rate was estimated to be 0.74%), and was higher than the previous peak (1.22% in 2006-07). The highest rates were consistently among those aged 25-34 years, in whom the rate of dependent use during 2012-2013 was estimated to be 1.50% (95% CI, 1.05-2.22%). There had also been an increase in the rate of dependent use among those aged 15-24 years (in 2012-13 reaching 1.14%; 95% CI, 0.80-1.69%). CONCLUSIONS: There have been increases over the past 12 years in the numbers of regular and dependent methamphetamine users in Australia. Our estimates suggest that the most recent numbers are the highest for this period, and that the increase has been most marked among young adults (those aged 15-34 years). IMPLICATIONS: There is an increasing need for health services to engage with people who have developed problems related to their methamphetamine use.
Authors: José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma Journal: Mol Neurobiol Date: 2018-01 Impact factor: 5.590
Authors: Alice Knight; Alys Havard; Anthony Shakeshaft; Myfanwy Maple; Mieke Snijder; Bernie Shakeshaft Journal: Int J Environ Res Public Health Date: 2017-02-20 Impact factor: 3.390
Authors: Sharful Islam Khan; Mohammad Niaz Morshed Khan; Samira Dishti Irfan; A M Rumayan Hasan; Allen G Ross; Lily Ming-Sha Horng; Nathan Lachowsky; Gail Knudson; Tasnim Azim Journal: Arch Sex Behav Date: 2020-04-01
Authors: Nadine Ezard; Adrian Dunlop; Michelle Hall; Robert Ali; Rebecca McKetin; Raimondo Bruno; Nghi Phung; Andrew Carr; Jason White; Brendan Clifford; Zhixin Liu; Marian Shanahan; Kate Dolan; Amanda L Baker; Nicholas Lintzeris Journal: BMJ Open Date: 2018-07-19 Impact factor: 2.692
Authors: Jia Yin Soo; Michael D Wiese; Rebecca M Dyson; Clint L Gray; Andrew N Clarkson; Janna L Morrison; Mary J Berry Journal: PLoS One Date: 2020-05-12 Impact factor: 3.240